Funding and Investments

SBIR Awards $1.4-Million Grant to Accelerate Antibody Manufacturing Technology

August 07, 2020

The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.

CDMOs Build Fill/Finish Capacity for COVID-19 Vaccines

August 01, 2020

Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine production.

Catalent Invests Millions to Create European Clinical Manufacturing Center of Excellence

July 21, 2020

Catalent has unveiled investment plans to create a European center of excellence for clinical biologics formulation development and drug product fill/finish services.

CureVac Receives Funding, Collaborates with GSK on mRNA and mAbs

July 21, 2020

GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.

VAR2 Pharmaceuticals Wins MilliporeSigma’s Advance Biotech Grant

July 08, 2020

VAR2 Pharmaceuticals has been selected for its development of a drug-conjugated malaria protein that potentially selectively binds to most human tumor types.

Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria

July 08, 2020

The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

July 02, 2020

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

EC Pledges Nearly $340 Million Additional Vaccine Funding to Gavi

June 08, 2020

The European Commission is pledging EUR 300 million (US$339 million) to Gavi for vaccines for infectious diseases, in addition to an earlier pledge of more than EUR 1.5 billion (US$1.7 billion) made on May 4, 2020.

Gavi Launches $2-Billion COVID-19 Vaccine Funding Initiative

June 04, 2020

The Gavi advance market commitment for COVID-19 vaccines is a new financing instrument aimed at incentivizing vaccine manufacturers to produce sufficient and affordable quantities of COVID-19 vaccines.

NIIMBL Funds Projects with $10 Million for Advances in Biopharma Manufacturing Innovation

May 20, 2020

This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.